Literature DB >> 19794069

Binding of DC-HIL to dermatophytic fungi induces tyrosine phosphorylation and potentiates antigen presenting cell function.

Jin-Sung Chung1, Tatsuo Yudate, Mizuki Tomihari, Hideo Akiyoshi, Ponciano D Cruz, Kiyoshi Ariizumi.   

Abstract

APCs express receptors recognizing microbes and regulating immune responses by binding to corresponding ligands on immune cells. Having discovered a novel inhibitory pathway triggered by ligation of DC-HIL on APC to a heparin/heparan sulfate-like saccharide of syndecan-4 on activated T cells, we posited DC-HIL can recognize microbial pathogens in a similar manner. We showed soluble recombinant DC-HIL to bind the dermatophytes Trichophyton rubrum and Microsporum audouinii, but not several bacteria nor Candida albicans. Dermatophyte binding was inhibited completely by the addition of heparin. Because DC-HIL contains an ITAM-like intracellular sequence, we questioned whether its binding to dermatophytes can induce tyrosine phosphorylation in dendritic cells (DC). Culturing DC with T. rubrum (but not with C. albicans pseudohyphae) induced phosphorylation of DC-HIL, but not when the tyrosine residue of the ITAM-like sequence was mutated to phenylalanine. To examine the functional significance of such signaling on DC, we cross-linked DC-HIL with mAb (surrogate ligand), which not only induced tyrosine phosphorylation but also up-regulated expression of 23 genes among 662 genes analyzed by gene-array, including genes for profilin-1, myristoylated alanine rich protein kinase C substrate like-1, C/EBP, LOX-1, IL-1beta, and TNF-alpha. This cross-linking also up-regulated expression of the activation markers CD80/CD86 and heightened APC capacity of DC to activate syngeneic T cells. Our findings support a dual role for DC-HIL: inhibition of adaptive immunity following ligation of syndecan-4 on activated T cells and induction of innate immunity against dermatophytic fungi.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19794069     DOI: 10.4049/jimmunol.0901319

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  The Arthroderma benhamiae hydrophobin HypA mediates hydrophobicity and influences recognition by human immune effector cells.

Authors:  Christoph Heddergott; Sandra Bruns; Sandor Nietzsche; Ines Leonhardt; Oliver Kurzai; Olaf Kniemeyer; Axel A Brakhage
Journal:  Eukaryot Cell       Date:  2012-03-09

2.  Generation and functional characterization of MDSC-like cells.

Authors:  Annkristin Heine; Stefanie Andrea Erika Held; Jonas Schulte-Schrepping; Julia Friederike Andrea Wolff; Kathrin Klee; Thomas Ulas; Niklas Arndt Schmacke; Solveig Nora Daecke; Kati Riethausen; Joachim L Schultze; Peter Brossart
Journal:  Oncoimmunology       Date:  2017-02-23       Impact factor: 8.110

Review 3.  Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  FASEB J       Date:  2020-05-23       Impact factor: 5.191

Review 4.  Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB) and Cancer: A Novel Potential Therapeutic Target.

Authors:  Manisha Taya; Stephen R Hammes
Journal:  Steroids       Date:  2017-10-31       Impact factor: 2.668

5.  GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis.

Authors:  G Maric; M G Annis; Z Dong; A A N Rose; S Ng; D Perkins; P A MacDonald; V Ouellet; C Russo; P M Siegel
Journal:  Oncogene       Date:  2015-03-16       Impact factor: 9.867

Review 6.  The Role of Phagocytes and NETs in Dermatophytosis.

Authors:  Fábio Seiti Yamada Yoshikawa; Sandro Rogério De Almeida
Journal:  Mycopathologia       Date:  2016-09-22       Impact factor: 2.574

7.  The DC-HIL/syndecan-4 pathway regulates autoimmune responses through myeloid-derived suppressor cells.

Authors:  Jin-Sung Chung; Kyoichi Tamura; Hideo Akiyoshi; Ponciano D Cruz; Kiyoshi Ariizumi
Journal:  J Immunol       Date:  2014-02-10       Impact factor: 5.422

8.  The DC-HIL ligand syndecan-4 is a negative regulator of T-cell allo-reactivity responsible for graft-versus-host disease.

Authors:  Jin-Sung Chung; Mizuki Tomihari; Kyoichi Tamura; Tetsuhito Kojima; Ponciano D Cruz; Kiyoshi Ariizumi
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

9.  Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer Patients.

Authors:  Masato Kobayashi; Jin-Sung Chung; Muhammad Beg; Yull Arriaga; Udit Verma; Kevin Courtney; John Mansour; Barbara Haley; Saad Khan; Yutaka Horiuchi; Vijay Ramani; David Harker; Purva Gopal; Farshid Araghizadeh; Ponciano D Cruz; Kiyoshi Ariizumi
Journal:  Clin Cancer Res       Date:  2018-07-26       Impact factor: 12.531

10.  Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer.

Authors:  Gordana Maric; April An Rose; Matthew G Annis; Peter M Siegel
Journal:  Onco Targets Ther       Date:  2013-07-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.